<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font24">and </span>
   <span class="font15">with </span>
   <span class="font15">al. </span>
   <span class="font14">for </span>
   <span class="font14">that </span>
   <span class="font14">;():â€�. </span>
   <span class="font13">SARSâ€�CoVâ€� </span>
   <span class="font13">viral </span>
   <span class="font13">antiviral </span>
   <span class="font12">are </span>
   <span class="font12">clinical </span>
   <span class="font12">virus </span>
   <span class="font12">The </span>
   <span class="font12">against </span>
   <span class="font12">protein </span>
   <span class="font12">treatment </span>
   <span class="font12">coronavirus </span>
   <span class="font12">{background </span>
   <span class="font11">have </span>
   <span class="font11">patients </span>
   <span class="font11">respiratory </span>
   <span class="font11">severe </span>
   <span class="font11">infection </span>
   <span class="font11">margin </span>
   <span class="font11">cell </span>
   <span class="font11">infected </span>
   <span class="font11">{border-style </span>
   <span class="font11">RNA </span>
   <span class="font11">has </span>
   <span class="font11">px;} </span>
   <span class="font11">their </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">been </span>
   <span class="font11">not </span>
   <span class="font11">these </span>
   <span class="font11">this </span>
   <span class="font11">;:â€". </span>
   <span class="font11">COVIDâ€� </span>
   <span class="font11">acute </span>
   <span class="font11">also </span>
   <span class="font11">from </span>
   <span class="font11">data </span>
   <span class="font11">syndrome </span>
   <span class="font11">Covidâ€� </span>
   <span class="font11">compounds </span>
   <span class="font11">effect </span>
   <span class="font11">human </span>
   <span class="font11">inhibitor </span>
   <span class="font11">replication </span>
   <span class="font11">trials </span>
   <span class="font11">activity </span>
   <span class="font11">life </span>
   <span class="font11">potential </span>
   <span class="font11">used </span>
   <span class="font10">Res. </span>
   <span class="font10">cells </span>
   <span class="font10">inhibitors </span>
   <span class="font10">limit </span>
   <span class="font10">other </span>
   <span class="font10">some </span>
   <span class="font10">studies </span>
   <span class="font10">ACE </span>
   <span class="font10">Accessed </span>
   <span class="font10">Antiviral </span>
   <span class="font10">This </span>
   <span class="font10">can </span>
   <span class="font10">currently </span>
   <span class="font10">different </span>
   <span class="font10">drugs </span>
   <span class="font10">efficacy </span>
   <span class="font10">infection. </span>
   <span class="font10">inhibits </span>
   <span class="font10">molecules </span>
   <span class="font10">protease </span>
   <span class="font10">results </span>
   <span class="font10">was </span>
   <span class="font10">April </span>
   <span class="font10">Med. </span>
   <span class="font10">Moreover, </span>
   <span class="font10">SARS </span>
   <span class="font10">SARSâ€�CoV </span>
   <span class="font10">action </span>
   <span class="font10">but </span>
   <span class="font10">first </span>
   <span class="font10">vitro </span>
   <span class="font10">Antimicrob </span>
   <span class="font10">Dis. </span>
   <span class="font10">Sci </span>
   <span class="font10">could </span>
   <span class="font10">entry </span>
   <span class="font10">immune </span>
   <span class="font10">into </span>
   <span class="font10">might </span>
   <span class="font10">mode </span>
   <span class="font10">receptor </span>
   <span class="font10">reduce </span>
   <span class="font10">shown </span>
   <span class="font10">study </span>
   <span class="font10">such </span>
   <span class="font10">therapeutic </span>
   <span class="font10">Azithromycin </span>
   <span class="font10">Clinical </span>
   <span class="font10">CoV </span>
   <span class="font10">Ebola </span>
   <span class="font10">Infect </span>
   <span class="font10">MoA </span>
   <span class="font10">Virol. </span>
   <span class="font10">already </span>
   <span class="font10">approved </span>
   <span class="font10">associated </span>
   <span class="font10">cells. </span>
   <span class="font10">cleavage </span>
   <span class="font10">convalescent </span>
   <span class="font10">cycle </span>
   <span class="font10">during </span>
   <span class="font10">favipiravir </span>
   <span class="font10">health </span>
   <span class="font10">influenza </span>
   <span class="font10">lung </span>
   <span class="font10">plasma </span>
   <span class="font10">px; </span>
   <span class="font10">recent </span>
   <span class="font10">several </span>
   <span class="font10">spike </span>
   <span class="font10">tested </span>
   <span class="font10">{font-family </span>
   <span class="font10">Ivermectin </span>
   <span class="font10">based </span>
   <span class="font10">broadâ€�spectrum </span>
   <span class="font10">chloroquine </span>
   <span class="font10">combination </span>
   <span class="font10">development </span>
   <span class="font10">disease </span>
   <span class="font10">drug </span>
   <span class="font10">effects </span>
   <span class="font10">font-size </span>
   <span class="font10">including </span>
   <span class="font10">inhibit </span>
   <span class="font10">its </span>
   <span class="font10">mesylate </span>
   <span class="font10">monoclonal </span>
   <span class="font10">new </span>
   <span class="font10">novel </span>
   <span class="font10">polymerase </span>
   <span class="font10">promising </span>
   <span class="font10">remdesivir </span>
   <span class="font10">showed </span>
   <span class="font10">target </span>
   <span class="font10">therapy </span>
   <span class="font10">trials. </span>
   <span class="font10">use </span>
   <span class="font10">which </span>
   <span class="font10">;():. </span>
   <span class="font10">;():â€". </span>
   <span class="font10">;:â€�. </span>
   <span class="font10">Acad </span>
   <span class="font10">Agents. </span>
   <span class="font10">Cell. </span>
   <span class="font10">FDAâ€�approved </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">Nat </span>
   <span class="font10">Natl </span>
   <span class="font10">Proc </span>
   <span class="font10">RdRp </span>
   <span class="font10">Rev </span>
   <span class="font10">These </span>
   <span class="font10">Virus </span>
   <span class="font10">alone </span>
   <span class="font10">antibodies </span>
   <span class="font10">basis </span>
   <span class="font10">control </span>
   <span class="font10">double; </span>
   <span class="font10">fusion </span>
   <span class="font10">identified </span>
   <span class="font10">important </span>
   <span class="font10">inhibition </span>
   <span class="font10">inâ€‰vitro </span>
   <span class="font10">mAbs </span>
   <span class="font10">may </span>
   <span class="font10">proteases </span>
   <span class="font10">public </span>
   <span class="font10">research </span>
   <span class="font10">ribavirin </span>
   <span class="font10">strategy </span>
   <span class="font10">two </span>
   <span class="font10">using </span>
   <span class="font10">were </span>
   <span class="font10">Although </span>
   <span class="font10">Biochem </span>
   <span class="font10">Chemother. </span>
   <span class="font10">European </span>
   <span class="font10">However, </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">MERSâ€�CoV </span>
   <span class="font10">Med </span>
   <span class="font10">NCT </span>
   <span class="font10">Proteases/inhibition </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">TMPRSS </span>
   <span class="font10">activation </span>
   <span class="font10">addition, </span>
   <span class="font10">azithromycin </span>
   <span class="font10">being </span>
   <span class="font10">bioRxiv. </span>
   <span class="font10">blocks </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cellular </span>
   <span class="font10">cohort </span>
   <span class="font10">cycle. </span>
   <span class="font10">developed </span>
   <span class="font10">due </span>
   <span class="font10">early </span>
   <span class="font10">effective </span>
   <span class="font10">endosomal </span>
   <span class="font10">epithelial </span>
   <span class="font10">genome </span>
   <span class="font10">key </span>
   <span class="font10">lopinavir/ritonavir </span>
   <span class="font10">needed </span>
   <span class="font10">neutralization </span>
   <span class="font10">neutralizing </span>
   <span class="font10">ongoing </span>
   <span class="font10">option </span>
   <span class="font10">polymerase/inhibition </span>
   <span class="font10">production </span>
   <span class="font10">proteins </span>
   <span class="font10">proâ€�inflammatory </span>
   <span class="font10">reported </span>
   <span class="font10">response </span>
   <span class="font10">role </span>
   <span class="font10">small </span>
   <span class="font10">solid; </span>
   <span class="font10">specific </span>
   <span class="font10">spread </span>
   <span class="font10">strategies </span>
   <span class="font10">targeting </span>
   <span class="font10">through </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Biol </span>
   <span class="font10">Bruno </span>
   <span class="font10">COVIDâ€�. </span>
   <span class="font10">Commun. </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">Coutard, </span>
   <span class="font10">Covidâ€�. </span>
   <span class="font10">East </span>
   <span class="font10">Engl </span>
   <span class="font10">HCQ </span>
   <span class="font10">HIV </span>
   <span class="font10">IFN </span>
   <span class="font10">Indeed, </span>
   <span class="font10">Int </span>
   <span class="font10">Kleineâ€�WeberH, </span>
   <span class="font10">Lancet. </span>
   <span class="font10">Marseille </span>
   <span class="font10">Middle </span>
   <span class="font10">More </span>
   <span class="font10">NCT, </span>
   <span class="font10">Nature. </span>
   <span class="font10">Nevertheless, </span>
   <span class="font10">SARSâ€�CoVâ€�: </span>
   <span class="font10">Several </span>
   <span class="font10">SimsAC, </span>
   <span class="font10">absence </span>
   <span class="font10">adverse </span>
   <span class="font10">analogs </span>
   <span class="font10">angiotensinâ€�converting </span>
   <span class="font10">animal </span>
   <span class="font10">antibody </span>
   <span class="font10">any </span>
   <span class="font10">arm </span>
   <span class="font10">assessed </span>
   <span class="font10">because </span>
   <span class="font10">block </span>
   <span class="font10">bold </span>
   <span class="font10">cells, </span>
   <span class="font10">compound </span>
   <span class="font10">compounds, </span>
   <span class="font10">courier; </span>
   <span class="font10">em; </span>
   <span class="font10">emerging </span>
   <span class="font10">enzyme </span>
   <span class="font10">https://www.biorxiv.org/content/./...v. </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">identify </span>
   <span class="font10">inhibitors. </span>
   <span class="font10">initially </span>
   <span class="font10">interferon </span>
   <span class="font10">interleukin </span>
   <span class="font10">known </span>
   <span class="font10">levels </span>
   <span class="font10">load </span>
   <span class="font10">mechanisms </span>
   <span class="font10">membrane </span>
   <span class="font10">mice </span>
   <span class="font10">molecular </span>
   <span class="font10">nuclear </span>
   <span class="font10">nucleoside </span>
   <span class="font10">potent </span>
   <span class="font10">pt;} </span>
   <span class="font10">recently, </span>
   <span class="font10">replication. </span>
   <span class="font10">review </span>
   <span class="font10">risk </span>
   <span class="font10">robust </span>
   <span class="font10">serine </span>
   <span class="font10">should </span>
   <span class="font10">show </span>
   <span class="font10">structural </span>
   <span class="font10">suggest </span>
   <span class="font10">than </span>
   <span class="font10">they </span>
   <span class="font10">transmembrane </span>
   <span class="font10">treatments </span>
   <span class="font10">trial </span>
   <span class="font10">umifenovir </span>
   <span class="font10">under </span>
   <span class="font10">Î±â€�ketoamide </span>
  </p>
 </body>
</html>
